Analysis of medical care of patients with type 2 diabetes enrolled in statutory or private health plans;Analyse der versorgungsqualität bei typ-2-diabetes bei gesetzlich und privat versicherten patienten

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 42, 2008, Pages 2143-2150

  Martin, Stephan ^a,b   Heinemann, L ^c   Lodwig, V ^d   Schneider, B ^e   Kolb, H ^b  

^a SANA KLINIKUM OFFENBACH   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c Profil Institut fur Stoffwechselforschung GmbH   (Germany)

^d Institut für Medizinische Informatik und Biostatistik   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Health plan; Observational study; Quality of care; ROSSO study; Type 2 diabetes mellitus

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHOLESTEROL; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRACTICE GUIDELINE; PRIVATE HEALTH INSURANCE; STROKE; BLOOD; BLOOD PRESSURE MEASUREMENT; CLASSIFICATION; COHORT ANALYSIS; GENERAL PRACTICE; GERMANY; HEALTH INSURANCE; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNAL MEDICINE; MIDDLE AGED; RETROSPECTIVE STUDY; STANDARD;

BLOOD PRESSURE DETERMINATION; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSURANCE, HEALTH; INTERNAL MEDICINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; STROKE;

EID: 53749098211     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1091254     Document Type: Article

References (22)

1. Berthold K, Gouni-Berthold I, Bestehorn K, Böhm M, Krone W. Kardiovaskuläre Risikofaktoren bei Typ 2 Diabetikern in Deutschland - ein Versorgungsparadox. Dtsch Arztebl 2007; 104: A861-A867
2. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003; 163 (17): 2006-2010
3. Gaede P, Vedel P, Larsen N, Jensen GV, Parang HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348 (5): 383-393
4. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuda: the Steno type 2 randomised study. Lancet 1999; 353 (9153): 617-622
5. Hauner H, Koster I, Ferber L von. Outpatient care of patients with diabetes mellitus in 2001. Analysis of a health insurance sample of the AOK in Hesse/KV in Hessen. Dtsch Med Wochenschr 2003; 128 (50): 2638-2643
6. Hauner H, Koster I, Ferber L von. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hessen. Dtsch Med Wochenschr 2003; 128 (50): 2632-2637
7. Icks A, Rathmann W, Haastert B et al. Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000. Dtsch Med Wochenschr 2006; 131 (3): 73-78
8. Koster I, Ferber L von, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006; 49 (7): 1498-1504
9. Lantech IM, Fueth R, Schotes D et al. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol 2006; 95: 80-87
10. Lehnert H, Wittchen HU, Pittrow D, Bramlage P, Kirch W, Bohler S et al. Prevalence and pharmacotherapy of diabetes mellitus in primary care. Dtsch Med Wochenschr 2005; 130(7): 323-328
11. Liebl A, Spannheimer A, Reitberger U, Gortz A. Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study. Med Klin (Munich) 2002; 97: 713-719
12. Martin S, Reipen M, van Leendert R, Beuth J, Kolb H, Scherbaum WA. Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990. Dtsch Med Wochenschr 2003; 128 (21): 1173-1178
13. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49 (2): 271-278
14. Martin S, Schramm W, Schneider B et al. Epidemiology of complications and total treatment costs from diagnosis of type 2 diabetes in Germany (ROSSO 4). Exp Clin Endocrinol Diabetes 2007; 115: 495-501
15. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46 (2): 182-189
16. Rothenbacher D, Ruter G, Saam S, Brenner H. Management of patients with type 2 diabetes. Results in 12 practices of general practitioners. Dtsch Med Wochenschr 2002; 127(22): 1183-1187
17. Schulze J, Rothe U, Muller G, Kunath H. Improvement of care for diabetics using the care model from Saxony. Dtsch Med Wochenschr 2003; 128 (21): 1161-1166
18. Stettler C, Allemann S, Juni P et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. American Heart Journal 2006; 152 (1): 27-38
19. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26 (3): 688-696
20. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
21. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865
22. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713